Home LiteratureArticle Details
PMID: 8642674 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation.

Journal of virology ·Vol. 70 ·No. 4 ·1996-04-00 ·Pages 2468-73

Yalamanchili R, Harada S, Kieff E

Abstract

Previous molecular genetic analyses of Epstein-Barr virus nuclear protein 2 (EBNA2) identified a negative effect of deletion of codons 19 to 33 on transformation and gene transactivation, while deletion of codons 19 to 110 was a null mutation for transformation and gene transactivation. We here report the surprising finding that codons 2 to 88, which encode the highly conserved unique N terminus (amino acids 1 to 58) and most of the polyproline repeat (amino acids 59 to 95), can be deleted with only minimal effects on transformation. Codons 97 to 122 can also be deleted with only minimal effects on transformation. However, deletion of 35 of the 37 prolines (amino acids 59 to 93) or deletion of codons 2 to 95 results in a null transforming phenotype. Although EBNA2 from which codons 59 to 93 were deleted was a null mutation for transformation, it was similar to some transforming mutants of EBNA2 in abundance, in interaction with RBPJK, and in transactivation of the LMP1 promoter in transient transfection assays. These data indicate that between three and seven prolines are critical for EBNA2 structure or for intermolecular interaction. Aside from these seven prolines, codons encoding the rest of the N-terminal half (amino acids 2 to 230) of EBNA2 are nonessential for primary B-lymphocyte growth transformation.

MeSH Terms
Antigens, Viral/genetics,physiology B-Lymphocytes/cytology,virology Base Sequence Cell Line Cell Transformation, Viral/genetics Codon Conserved Sequence DNA, Viral DNA-Binding Proteins/genetics,physiology Epstein-Barr Virus Nuclear Antigens Herpesvirus 4, Human/genetics,physiology Molecular Sequence Data Proline/physiology Sequence Deletion Tumor Cells, Cultured Viral Matrix Proteins/biosynthesis
Chemicals
Antigens, Viral Codon DNA, Viral DNA-Binding Proteins EBV-associated membrane antigen, Epstein-Barr virus Epstein-Barr Virus Nuclear Antigens Viral Matrix Proteins Proline
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Yalamanchili R
Department of Microbiology and Molecular Genetics, Harvard University, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Harada S
Kieff E
References (25)
25 references, click to expand
  1. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7819-23 PMID: 7644498
  2. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.
    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3259-63 PMID: 7724549
  3. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Proc Natl Acad Sci U S A. 1974 Oct;71(10):4006-10 PMID: 4372601
  4. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
    Biomedicine. 1975 Jul;22(4):276-84 PMID: 179629
  5. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
    Proc Natl Acad Sci U S A. 1984 Dec;81(23):7632-6 PMID: 6209719
  6. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  7. The Epstein-Barr virus proteins.
    Adv Cancer Res. 1988;50:95-158 PMID: 2837072
  8. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    J Virol. 1989 Apr;63(4):1531-9 PMID: 2538644
  9. Antigen receptor tail clue.
    Nature. 1989 Mar 30;338(6214):383-4 PMID: 2927501
  10. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  11. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  12. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    J Virol. 1990 Mar;64(3):1002-13 PMID: 2154588
  13. Early events in Epstein-Barr virus infection of human B lymphocytes.
    Virology. 1991 Apr;181(2):595-608 PMID: 1849678
  14. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  15. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    J Virol. 1991 Dec;65(12):6765-71 PMID: 1658373
  16. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    EMBO J. 1993 Jan;12(1):167-75 PMID: 8381349
  17. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    J Virol. 1993 Jun;67(6):2990-3003 PMID: 8388484
  18. Structural basis for the binding of proline-rich peptides to SH3 domains.
    Cell. 1994 Mar 11;76(5):933-45 PMID: 7510218
  19. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
    Science. 1994 Jul 1;265(5168):92-5 PMID: 8016657
  20. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7568-72 PMID: 8052621
  21. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    J Virol. 1994 Oct;68(10):6188-97 PMID: 8083959
  22. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Virology. 1994 Nov 1;204(2):634-41 PMID: 7941331
  23. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    J Virol. 1995 Jan;69(1):253-62 PMID: 7983717
  24. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.
    J Virol. 1995 Jan;69(1):585-8 PMID: 7983760
  25. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE.
    Mol Cell Biol. 1995 Sep;15(9):4735-44 PMID: 7651391
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-04-00
Pages
2468-73
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC190090
Subset
IM
Grants
NIAID NIH HHS · AI08548-02 · United States
NCI NIH HHS · CA47006 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]